Zobrazeno 1 - 4
of 4
pro vyhledávání: '"fat mapping"'
Autor:
Lisa Richards, Jeffrey Cui, H. Aryafar, Jonathan Hooker, Phirum Nguyen, Rohit Loomba, Ricki Bettencourt, Archana Bhatt, Catherine A. Hooker, Mark A. Valasek, Janki Patel, William Haufe, Joanie Salotti, Carolyn Hernandez, Claude B. Sirlin
Publikováno v:
Therapeutic advances in gastroenterology, vol 9, iss 5
Patel, J; Bettencourt, R; Cui, J; Salotti, J; Hooker, J; Bhatt, A; et al.(2016). Association of noninvasive quantitative decline in liver fat content on MRI with histologic response in nonalcoholic steatohepatitis. THERAPEUTIC ADVANCES IN GASTROENTEROLOGY, 9(5), 692-701. doi: 10.1177/1756283X16656735. UC San Diego: Retrieved from: http://www.escholarship.org/uc/item/7s60013q
Therapeutic Advances in Gastroenterology, Vol 9 (2016)
Patel, J; Bettencourt, R; Cui, J; Salotti, J; Hooker, J; Bhatt, A; et al.(2016). Association of noninvasive quantitative decline in liver fat content on MRI with histologic response in nonalcoholic steatohepatitis. THERAPEUTIC ADVANCES IN GASTROENTEROLOGY, 9(5), 692-701. doi: 10.1177/1756283X16656735. UC San Diego: Retrieved from: http://www.escholarship.org/uc/item/7s60013q
Therapeutic Advances in Gastroenterology, Vol 9 (2016)
Background: Magnetic resonance imaging-estimated proton-density-fat-fraction (MRI-PDFF) has been shown to be a noninvasive, accurate and reproducible imaging-based biomarker for assessing steatosis and treatment response in nonalcoholic steatohepatit
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4b0c3fc6ec817d99a447914a542947d0
https://escholarship.org/uc/item/7s60013q
https://escholarship.org/uc/item/7s60013q
Autor:
William Haufe, Jonathan Hooker, David A. Brenner, Lisa Richards, Joanie Salotti, Jeffrey Cui, Catherine A. Hooker, Len Philo, Ricki Bettencourt, Carolyn Hernandez, Rohit Loomba, Heather Hofflich, Archana Bhatt, Claude B. Sirlin, Phirum Nguyen
Publikováno v:
Journal of hepatology, vol 65, iss 2
Cui, J; Philo, L; Nguyen, P; Hofflich, H; Hernandez, C; Bettencourt, R; et al.(2016). Sitagliptin vs. placebo for non-alcoholic fatty liver disease: A randomized controlled trial. JOURNAL OF HEPATOLOGY, 65(2), 369-376. doi: 10.1016/j.jhep.2016.04.021. UC San Diego: Retrieved from: http://www.escholarship.org/uc/item/72b7v8b3
Cui, J; Philo, L; Nguyen, P; Hofflich, H; Hernandez, C; Bettencourt, R; et al.(2016). Sitagliptin vs. placebo for non-alcoholic fatty liver disease: A randomized controlled trial. JOURNAL OF HEPATOLOGY, 65(2), 369-376. doi: 10.1016/j.jhep.2016.04.021. UC San Diego: Retrieved from: http://www.escholarship.org/uc/item/72b7v8b3
Background & aimsUncontrolled studies show sitagliptin, an oral DPP-4 inhibitor, may improve alanine aminotransferase and liver histology in non-alcoholic fatty liver disease (NAFLD) patients. We aimed to compare sitagliptin vs. the efficacy of a pla
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cab56ed23895f88a8a16a0628e49fca0
https://escholarship.org/uc/item/72b7v8b3
https://escholarship.org/uc/item/72b7v8b3
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.